Image via The Next Web (TNW)
HistoSonics: Geographic Expansion
HistoSonics received regulatory approval from Taiwan's FDA for its Edison Histotripsy System, marking a significant step in expansion into Asia
Source: The Next Web (TNW)
The leadership read
Market entry of this kind typically deepens demand for medtech leadership bench strength in the region over the following 12–18 months.
Market context: the MitchelLake Talent Market Index reads 108.5 — Hot (+10.8 vs prior month); Americas signal share is easing (-9.8pts).
Market entry — the MitchelLake playbook
When a company expands into a new market, the first leadership hires decide whether it lands. A selection of market entries we've run:
All market-entry case studies →MitchelLake in this thematic
Our work · 2022
Head of eCommerce and Consumer Experience (CX) / GM North America
LittleOak
Americas · Ecommerce · cross-border · ecommerce-growth
Our work · 2019
VP of Sales, Americas
Longtail UX
Americas · MarTech/SEO/SEM · first us hire · cross border
Our work · 2019
VP Sales (US) / CEO
Multiple (Longtail UX, Genbook)
Americas · Technology/SaaS · founder-transition · international-expansion
More signals across MedTech
Product Launch · Americas
Orchid →Vancouver-based AI startup Orchid launched a free World Cup experience allowing fans to receive live scores, match information, and local guidance through text messaging. This consumer-facing launch demonstrates the broader AI personal assistant platform capabilities for real-time experiences beyond workplace productivity.
Geographic Expansion · Oceania
Medtronic →Medtronic is expanding its Stealth AXiS product line into European markets
Partnership · EMEA
Cepheid →Cepheid launched landmark 30-month study with the Fleming Initiative at London NHS Trusts to evaluate rapid CPE screening for drug-resistant infections
Product Launch · EMEA
ZEISS Medical Technology →ZEISS successfully completed early clinical implantations of AT LUCIA toric 721P intraocular lens across six European countries. Product is CE marked and expected to launch commercially in select European markets later in 2026.
Capital Raising · EMEA
Nanordica Medical →Estonia-based Nanordica Medical raised €1.6M to bring its antibiotic-free chronic wound treatment to market and complete clinical trials ahead of European launch.
Capital Raising · Oceania
EBR Systems →EBR Systems secured underwriting for A$150 million CDI offer at A$0.38 per security